Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Shanghai Micurx Pharmaceutical (688373)
- 6.02
- +0.05+0.84%
Market Closed Apr 30 15:00 CST
3.95BMarket Cap-19.61P/E (TTM)
6.12High5.96Low7.52MlotVolume5.97Open5.97Prev Close45.37MTurnover1.24%Turnover RatioLossP/E (Static)656.23MShares10.3152wk High21.73P/B3.65BFloat Cap5.5252wk Low7.16Limit Up605.64MShs Float14.20Historical High4.78Limit Down2.68%Range %3.23Historical Low--Dividend TTM6.03Avg Price2.94MlotAsk--Div Yield TTM1Lot Size4.36MlotBid
Shanghai Micurx Pharmaceutical (688373) Cash Flow
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 45.08%50.88M | 12.95%154.24M | 11.93%110.48M | 10.82%71.05M | 7.68%35.07M | 49.38%136.56M | 41.03%98.7M | 60.23%64.12M | 63.19%32.57M | 102.74%91.42M |
| Refunds of taxes and levies | ---- | ---- | ---- | ---- | -92.73%7.12K | ---- | -99.24%97.88K | -99.24%97.88K | -99.24%97.88K | 74.85%12.84M |
| Cash received relating to other operating activities | 2,252.27%11.43M | 134.23%8.39M | 125.59%7.23M | 27.42%3.14M | -48.08%486.11K | -6.34%3.58M | -0.74%3.2M | 14.24%2.47M | -43.03%936.26K | -81.32%3.83M |
| Cash inflows from operating activities | 75.23%62.31M | 16.05%162.64M | 15.39%117.71M | 11.27%74.2M | 5.83%35.56M | 29.66%140.15M | 18.53%102.01M | 21.20%66.68M | -2.44%33.6M | 48.23%108.09M |
| Goods services cash paid | 17.78%55.25M | -40.73%246.33M | -33.21%182.87M | -39.98%121.95M | -49.66%46.91M | 31.41%415.61M | 28.41%273.81M | 69.23%203.17M | 74.44%93.19M | 46.43%316.26M |
| Staff behalf paid | -29.70%21.18M | -7.09%103.14M | 1.52%79.62M | -5.80%54.79M | -8.47%30.13M | 5.44%111.02M | -0.77%78.43M | 7.65%58.16M | 11.19%32.92M | 18.78%105.29M |
| All taxes paid | 9.86%1.13M | -54.73%12.22M | -60.12%10.97M | -58.91%10.46M | -76.34%1.03M | 807.41%27M | 1,383.36%27.51M | 2,415.26%25.45M | 1,183.37%4.35M | 2,000.57%2.98M |
| Cash paid relating to other operating activities | -92.05%757.69K | -67.00%11.12M | -37.30%9.87M | -13.64%7.7M | 146.05%9.53M | 166.49%33.71M | -5.81%15.74M | -23.28%8.92M | 21.73%3.87M | 54.95%12.65M |
| Cash outflows from operating activities | -10.60%78.32M | -36.52%372.82M | -28.36%283.34M | -34.09%194.9M | -34.78%87.61M | 34.35%587.33M | 27.23%395.49M | 58.37%295.7M | 55.21%134.33M | 39.70%437.17M |
| Net cash flows from operating activities | 69.23%-16.01M | 53.00%-210.18M | 43.57%-165.63M | 47.30%-120.7M | 48.33%-52.05M | -35.89%-447.18M | -30.57%-293.49M | -73.89%-229.02M | -93.31%-100.73M | -37.11%-329.08M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -18.98%687.19M | -10.89%2.66B | 3.29%1.93B | 12.75%1.39B | 33.90%848.17M | -23.10%2.99B | -37.32%1.86B | -40.47%1.23B | -36.55%633.45M | 159.31%3.88B |
| Cash received from returns on investments | -84.60%1.33M | -66.39%6.78M | -86.81%5.35M | -76.50%3.72M | -31.71%8.62M | -45.55%20.17M | 39.56%40.58M | -17.20%15.83M | 46.34%12.62M | 149.39%37.05M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | -86.20%3.79K | -86.47%3.79K | ---- | ---- | --27.46K | --28K | --28K | ---- | ---- |
| Cash inflows from investing activities | -19.64%688.52M | -11.26%2.67B | 1.36%1.93B | 11.62%1.4B | 32.62%856.79M | -23.31%3.01B | -36.57%1.9B | -40.26%1.25B | -35.84%646.07M | 158.95%3.92B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 7.23%24.86K | -39.98%549.09K | 1,216.13%631.74K | 441.53%259.93K | -51.69%23.19K | -88.06%914.77K | -99.25%48K | -99.20%48K | -98.68%48K | -37.09%7.66M |
| Cash paid to acquire investments | -18.06%666.09M | 0.44%2.5B | 12.01%1.75B | 29.05%1.36B | 66.51%812.86M | -30.38%2.49B | -42.74%1.57B | -41.47%1.05B | -47.67%488.19M | 60.10%3.58B |
| Cash outflows from investing activities | -18.06%666.12M | 0.43%2.5B | 12.05%1.75B | 29.07%1.36B | 66.49%812.89M | -30.51%2.49B | -42.87%1.57B | -41.66%1.05B | -47.86%488.24M | 59.57%3.59B |
| Net cash flows from investing activities | -48.98%22.4M | -67.85%165.49M | -47.90%176.89M | -81.05%37.54M | -72.18%43.9M | 53.84%514.8M | 29.02%339.49M | -31.52%198.14M | 123.69%157.83M | 145.63%334.63M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | 57.53%3.11M | ---- | ---- | ---- | --1.98M | ---- | ---- | ---- | ---- |
| Cash from borrowing | ---- | 95.91%205.7M | -8.30%91.7M | 19.50%71.7M | 114.93%64.48M | 75.00%105M | 66.67%100M | 50.00%60M | -25.00%30M | -59.66%60M |
| Cash inflows from financing activities | ---- | 95.20%208.82M | -8.30%91.7M | 19.50%71.7M | 114.93%64.48M | 78.30%106.98M | 66.67%100M | 50.00%60M | -25.00%30M | -94.69%60M |
| Borrowing repayment | 87.53%10.31M | 584.23%116.46M | 88.04%19.74M | 71.57%12.01M | 175.00%5.5M | -71.53%17.02M | -80.46%10.5M | -86.73%7M | -95.81%2M | -14.61%59.77M |
| Dividend interest payment | 64.78%3.34M | 35.66%8.88M | 43.10%6.52M | 61.39%4.3M | 69.38%2.03M | 42.19%6.54M | 41.60%4.55M | 26.21%2.67M | 22.25%1.2M | 39.45%4.6M |
| Cash payments relating to other financing activities | --202.8K | -0.94%15.18M | 3.39%11.39M | 4.26%7.72M | ---- | 0.57%15.32M | -3.60%11.02M | -5.38%7.4M | --3.75M | -47.61%15.23M |
| Cash outflows from financing activities | 84.09%13.86M | 261.36%140.51M | 44.42%37.65M | 40.80%24.03M | 8.43%7.53M | -51.16%38.88M | -61.88%26.07M | -72.77%17.07M | -85.75%6.94M | -22.24%79.61M |
| Net cash flows from financing activities | -124.33%-13.86M | 0.32%68.31M | -26.89%54.05M | 11.04%47.67M | 147.00%56.95M | 447.31%68.09M | 982.10%73.93M | 289.38%42.93M | 364.83%23.06M | -101.91%-19.61M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -240.11%-347.22K | -1,509.44%-2.02M | 52.61%-1.61M | 12.17%-934.22K | 89.50%-102.09K | -67.80%143.37K | -78.32%-3.39M | -465.81%-1.06M | 43.78%-972.58K | -61.55%445.28K |
| Net increase in cash and cash equivalents | -116.05%-7.82M | -84.10%21.6M | -45.34%63.7M | -431.59%-36.43M | -38.49%48.71M | 1,098.19%135.86M | 315.18%116.54M | -91.88%10.99M | 888.42%79.18M | -124.36%-13.61M |
| Add:Begin period cash and cash equivalents | 7.90%294.94M | 98.82%273.33M | 98.82%273.33M | 98.82%273.33M | 98.82%273.33M | -9.01%137.48M | -9.01%137.48M | -9.01%137.48M | -9.01%137.48M | 58.69%151.09M |
| End period cash equivalent | -10.84%287.12M | 7.90%294.94M | 32.68%337.03M | 59.57%236.91M | 48.64%322.04M | 98.82%273.33M | 41.78%254.01M | -48.15%148.46M | 36.18%216.66M | -9.01%137.48M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | -- | -- | PwC Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm